Cardiac amyloidosis across the spectrum of left ventricular function: multimodal functional and prognostic insights
CA affects the full spectrum of LVEF phenotypes. The integration of LVEF, GLS and CIx improves prognostic stratification and argues in favour of a multimodal imaging approach for early diagnosis and individualised management.
Authors
- Shirley Odouard
- D. Tixier
- Mounira Kharoubi (ORCID: https://orcid.org/0000-0001-8942-2506)
- Amaury Broussier (ORCID: https://orcid.org/0000-0003-1137-9864)
- Emmanuel Teíger (ORCID: https://orcid.org/0000-0001-7515-4344)
- Silvia Oghina (ORCID: https://orcid.org/0000-0003-0108-5598)
- Amira Zaroui (ORCID: https://orcid.org/0000-0002-4827-4057)
- O Lairez
- Thibaud Damy
- Safaa Mehenni
- Erwan Donal
- Sabrina Belaidi
Institutions
- Inserm (FR)
- Université Fédérale de Toulouse Midi-Pyrénées (FR)
- Université Paris-Est Créteil (FR)
- Centre Hospitalier Universitaire Henri-Mondor (FR)
- Centre Hospitalier Universitaire de Toulouse (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Amyloidosis Foundation (US)
- Société Française d'Exportation des Ressources Éducatives (FR)
- Hôpitaux Universitaires Henri-Mondor (FR)
- Centre Hospitalier Universitaire de Rennes (FR)
- French Clinical Research Infrastructure Network (FR)
Publication Details
- Journal
- Heart
- Published
- 2026-03-13
- DOI
- https://doi.org/10.1136/heartjnl-2025-327260
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer
- AstraZeneca
- Alexion Pharmaceuticals